Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alexza's Last Stand: Hoping For Buyout Or License Of Adasuve

This article was originally published in The Pink Sheet Daily

Executive Summary

Facing a potential shutdown at the end of April, the California drug-delivery firm hopes either to be purchased by its Spanish partner or find a new licensee of US rights to its inhalable antipsychotic.

Advertisement

Related Content

Alexza Finds New U.S. Marketing Partner For Adasuve In Teva

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS079257

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel